| Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes a controlled clinical trial LJ Cheskin, AM Mitchell, AD Jhaveri, AH Mitola, LM Davis, RA Lewis, ... The Diabetes Educator 34 (1), 118-127, 2008 | 147 | 2008 |
| Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function SY Wu, F Xing, S Sharma, K Wu, A Tyagi, Y Liu, D Zhao, RP Deshpande, ... Journal of Experimental Medicine 217 (8), e20191131, 2020 | 72 | 2020 |
| Lack of energy compensation over 4 days when white button mushrooms are substituted for beef LJ Cheskin, LM Davis, LM Lipsky, AH Mitola, T Lycan, V Mitchell, B Mickle, ... Appetite 51 (1), 50-57, 2008 | 59 | 2008 |
| Severe neurologic complications of immune checkpoint inhibitors: a single-center review S Mancone, T Lycan, T Ahmed, U Topaloglu, A Dothard, WJ Petty, ... Journal of neurology 265, 1636-1642, 2018 | 54 | 2018 |
| A phase II clinical trial of CPI-613 in patients with relapsed or refractory small cell lung carcinoma TW Lycan, TS Pardee, WJ Petty, M Bonomi, A Alistar, ZS Lamar, S Isom, ... PloS one 11 (10), e0164244, 2016 | 54 | 2016 |
| Patient-reported outcomes from patients receiving immunotherapy or chemoimmunotherapy for metastatic non–small-cell lung cancer in clinical practice LES McLouth, TW Lycan Jr, BJ Levine, J Gabbard, J Ruiz, M Farris, ... Clinical lung cancer 21 (3), 255-263. e4, 2020 | 43 | 2020 |
| SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis L Liu, T Ahmed, WJ Petty, S Grant, J Ruiz, TW Lycan, U Topaloglu, ... Molecular oncology 15 (2), 462-472, 2021 | 36 | 2021 |
| Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation RT Hughes, WJ Beuerlein, SS O'Neill, M Porosnicu, TW Lycan, ... Oral oncology 98, 20-27, 2019 | 31 | 2019 |
| Performance status and age as predictors of immunotherapy outcomes in advanced non–small-cell lung cancer T Ahmed, T Lycan, A Dothard, P Ehrlichman, J Ruiz, M Farris, ... Clinical lung cancer 21 (4), e286-e293, 2020 | 29 | 2020 |
| Limited-stage small cell lung cancer: is prophylactic cranial irradiation necessary? MK Farris, WH Wheless, RT Hughes, MH Soike, AH Masters, CA Helis, ... Practical Radiation Oncology 9 (6), e599-e607, 2019 | 27 | 2019 |
| Relationship between tumor mutational burden, PD-L1, patient characteristics, and response to immune checkpoint inhibitors in head and neck squamous cell carcinoma KM Burcher, JW Lantz, E Gavrila, A Abreu, JT Burcher, AT Faucheux, ... Cancers 13 (22), 5733, 2021 | 22 | 2021 |
| Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases M Abdulhaleem, H Johnston, R D’Agostino Jr, C Lanier, M LeCompte, ... Journal of Neuro-Oncology 157 (1), 101-107, 2022 | 21 | 2022 |
| Unmet care needs and financial hardship in patients with metastatic non–small-cell lung cancer on immunotherapy or chemoimmunotherapy in clinical practice LE McLouth, CL Nightingale, BJ Levine, JL Burris, JA McDougall, ... JCO Oncology Practice 17 (8), e1110-e1119, 2021 | 21 | 2021 |
| Workflow differences affect data accuracy in oncologic EHRs: a first step toward detangling the diagnosis data babel F Diaz-Garelli, R Strowd, VL Lawson, ME Mayorga, BJ Wells, TW Lycan Jr, ... JCO Clinical Cancer Informatics 4, 529-538, 2020 | 16 | 2020 |
| Prevalence of DNA repair gene mutations in blood and tumor tissue and impact on prognosis and treatment in HNSCC KM Burcher, AT Faucheux, JW Lantz, HL Wilson, A Abreu, K Salafian, ... Cancers 13 (13), 3118, 2021 | 14 | 2021 |
| Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer TW Lycan, FC Hsu, CS Ahn, A Thomas, FO Walker, OP Sangueza, ... Muscle & nerve 61 (5), 587-594, 2020 | 14 | 2020 |
| Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery N Alphonse-Sullivan, GB Taksler, T Lycan, KE Weaver, ER McTyre, ... Oncotarget 8 (60), 101005, 2017 | 13 | 2017 |
| A case report of immune checkpoint inhibitor‐induced aortitis treated with tocilizumab CH Bloomer, RV Annabathula, V Aggarwal, B Upadhya, TW Lycan Case Reports in Immunology 2022 (1), 7971169, 2022 | 8 | 2022 |
| Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy MR Smith, Y Wang, R D’Agostino Jr, Y Liu, J Ruiz, T Lycan, G Oliver, ... NPJ Precision Oncology 7 (1), 34, 2023 | 6 | 2023 |
| Prognostic awareness, palliative care use, and barriers to palliative care in patients undergoing immunotherapy or chemo-immunotherapy for metastatic lung cancer LE McLouth, J Gabbard, BJ Levine, SL Golden, TW Lycan, WJ Petty, ... Journal of Palliative Medicine 26 (6), 831-836, 2023 | 5 | 2023 |
Jimmy Ruiz, MDAtrium Health - Wake Forest Comprehensive Cancer Center在 wakehealth.edu 的电子邮件经过验证
